A novel in situ self-dissolving needle web based on medicated cellulose hollow fibres with drug delivery features

Open Medical Devices Journal

Volumn 3, Issue , 2011, Pages 1-8

  Hoefer, Dirk ^a   Hohn, Gregor ^a   Berner Dannenmann, Nadja ^a   Schulze, Thomas ^b   Niemz, Frank Günther ^b   Hammer, Timo R ^a  

^a Hohenstein Institutes   (Germany)

^b Thueringisches Institut fuer Textil und Kunststoff Forschung eV   (Germany)

Author keywords

Bacteriophages; Biotherapy; Cellulase; Chronic wounds; Krillase ; Viscose; Wound dressing

Indexed keywords

CELLULASE; CELLULOSE; KRILLASE; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ARTICLE; BIODEGRADATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME RELEASE; FREEZE DRYING; HOLLOW FIBER; HOLLOW FIBER NEEDLE WEB; IN VITRO STUDY; POLYMERIZATION; PRIORITY JOURNAL; PSEUDOMONAS PHAGE; STEADY STATE; SUSTAINED DRUG RELEASE; VISCOSITY; WOUND DRESSING;

EID: 84855742310     PISSN: None     EISSN: 18751814     Source Type: Journal    
DOI: 10.2174/1875181401103010001     Document Type: Article

References (53)

1. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin 1993; 11(4): 629-40.
2. Percival JN. Classification of wounds and their management. Surgery 2002; 20: 114-7.
3. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ 2002; 324(7330): 160-3.
4. Moore K, McCallion R, Searle RJ, Stacey MC, Harding KG. Prediction and monitoring the therapeutic response of chronic dermal wounds. Int Wound J 2006; 3(2): 89-96.
5. Winter GD, Scales JT. Effect of air drying and dressings on the surface of a wound. Nature 1963; 197: 91-2.
6. Turner T. Today's products and wound management. Nurs Mirror 1979; 148(25): i-xvi.
7. Eccleston GM. In Aulton ME, Ed. Pharmaceutics: The science of dosage form design. 3rd edition. UK: Churchill Livingstone 2007; pp. 264-71.
8. Goldman R. Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care 2004; 17(1): 24-35.
9. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. J Pharm Sci 2008; 97(8): 2892-923.
10. Heenan A. Dressings on the drug tariff. Wales, UK: 1998.
11. Zavan B, Vindigni V, Vezzu K, et al. Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J Mater Sci Mater Med 2009; 20(1): 235-47.
12. Imaz I, Rubio-Martinez M, Garcia-Fernandez L, et al. Coordination polymer particles as potential drug delivery systems. Chem Commun (Camb) 2010; 46(26): 4737-9
13. Bourke SL, Al-Khalili M, Briggs T, Michniak BB, Kohn J, Poole- Warren LA. A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS PharmSci 2003; 5(4): E33.
14. Elsner JJ, Zilberman M. Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties. Acta Biomater 2009; 5(8): 2872-83.
15. Hellgren L, Mohr V, Vincent J. Proteases of Antarctic krill - a new system for effective enzymatic debridement of necrotic ulcerations. Experientia 1986; 42(4): 403-4.
16. Mekkes JR, Le Poole IC, Das PK, Kammeyer A, Westerhof W. In vitro tissue-digesting properties of krill enzymes compared with fibrinolysin/ DNAse, papain and placebo. Int J Biochem Cell Biol 1997; 29(4): 703-6.
17. Chanishvili N, Chanishvili T, Tediashvili M, Barrow PA. Phages and their application against drug-resistant bacteria. J Chem Technol Biot 2001; 76: 689-99.
18. Kutter B, Raya R, Guttman B, Brabban A, Neitzel J. Lab Procedures. The Evergreen State College 2004.
19. Ceyssens PJ, Lavigne R, Mattheus W, et al. Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup. J Bacteriol 2006; 188(19): 6924-31.
20. Erlanger BF, Kokowsky N, Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961; 95: 271-8.
21. Elsner JJ, Berdicevsky I, Zilberman M. In vitro microbial inhibition and cellular response to novel biodegradable composite wound dressings with controlled release of antibiotics. Acta Biomater 2011; 7(1): 325-36.
22. Kumar TR, Vasantha Bai M, Krishnan LK. A freeze-dried fibrin disc as a biodegradable drug release matrix. Biologicals 2004; 32(1): 49-55.
23. Lawrence JC. A povidone-iodine medicated dressing. J Wound Care 1998; 7(7): 332-6.
24. Sawada Y, Ara M, Yotsuyanagi T, Sone K. Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet. Burns 1990; 16(5): 347-52.
25. Sawada Y, Ohkubo T, Kudoh M, Sugawara K, Otani K, Sasaki J. An evaluation of a new lactic acid polymer drug delivery system: a preliminary report. Br J Plast Surg 1994; 47(3): 158-61.
26. Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater 2009; 5(7): 2570-8.
27. Gimeno MJ, Garcia-Esteo F, Garcia-Honduvilla N, San Roman J, Bellon JM, Bujan J. A novel controlled drug-delivery system for growth hormone applied to healing skin wounds in diabetic rats. J Biomater Sci Polym Ed 2003; 14(8): 821-35.
28. Wallace E. Feeding the wound: nutrition and wound care. Br J Nurs 1994; 3(13): 662-7.
29. Blanchemain N, Haulon S, Martel B, Traisnel M, Morcellet M, Hildebrand HF. Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system. Eur J Vasc Endovasc Surg 2005; 29(6): 628-32.
30. Sripriya R, Kumar MS, Sehgal PK. Improved collagen bilayer dressing for the controlled release of drugs. J Biomed Mater Res B Appl Biomater 2004; 70(2): 389-96.
31. Wang Y, Wang B, Qiao W, Yin T. A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles. J Pharm Sci 2010; 99(12): 4805-11.
32. Craig SJ, Shu A, Xu Y, Foong FC, Nordon R. Chimeric protein for selective cell attachment onto cellulosic substrates. Protein Eng Des Sel 2007; 20(5): 235-41.
33. Comfort AR, Albert E, Langer R. Immobilized enzyme cellulose hollow fibers: II. Kinetic analysis. Biotechnol Bioeng 1989; 34(11): 1374-82.
34. Comfort AR, Albert EC, Langer R. Immobilized enzyme cellulose hollow fibers: I. Immobilization of heparinase. Biotechnol Bioeng 1989; 34(11): 1366-73.
35. Comfort AR, Berkowitz S, Albert E, Langer R. Immobilized enzyme cellulose hollow fibers: III. Physical properties and in vitro biocompatibility. Biotechnol Bioeng 1989; 34(11): 1383-90.
36. Hellgren K. Assessment of Krillase chewing gum for the reduction of gingivitis and dental plaque. J Clin Dent 2009; 20(3): 99-102.
37. Mann NH. The potential of phages to prevent MRSA infections. Res Microbiol 2008; 159(5): 400-5.
38. Hohn G, Müller M, Höfer D. Fiber-based approaches for innovative wound care. Proceedings FiberMed 11, International Conference on Fibrous Products in Medical and Health Care, 28-30 June 2011, Tampere, Finland 2011.
39. Frenning G, Tunon A, Alderborn G. Modelling of drug release from coated granular pellets. J Control Release 2003; 92(1-2): 113-23.
40. Hancock BC, York P, Rowe RC. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm 1997; 148: 1-21.
41. Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006; 23(10): 2417-26.
42. Sheihet L, Piotrowska K, Dubin RA, Kohn J, Devore D. Effect of tyrosine-derived triblock copolymer compositions on nanosphere self-assembly and drug delivery. Biomacromolecules 2007; 8(3): 998-1003.
43. Soriano I, Evora C. Formulation of calcium phosphates/poly (d,llactide) blends containing gentamicin for bone implantation. J Control Release 2000; 68(1): 121-34.
44. Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006; 27(23): 4239-49.
45. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006; 27(11): 2450-67.
46. Mekkes JR, Le Poole IC, Das PK, Bos JD, Westerhof W. Efficient debridement of necrotic wounds using proteolytic enzymes derived from Antarctic krill: a double-blind, placebo-controlled study in a standardized animal wound model. Wound Repair Regen 1998; 6(1): 50-7.
47. Smith F, Dryburgh N, Donaldson J, Mitchell M. Debridement for surgical wounds. Cochrane Database Syst Rev 2011; 5: CD006214.
48. Singer AJ, McClain SA, Taira BR, Rooney J, Steinhauff N, Rosenberg L. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis. J Burn Care Res 2010; 31(2): 304-9.
49. Ramundo J, Gray M. Collagenase for enzymatic debridement: a systematic review. J Wound Ostomy Continence Nurs 2009; 36(6 Suppl): S4-11.
50. Hafezi F, Rad HE, Naghibzadeh B, Nouhi A, Naghibzadeh G. Actinidia deliciosa (kiwifruit), a new drug for enzymatic debridement of acute burn wounds. Burns 2009; 36(3): 352-5.
51. Schultz G, Mozingo D, Romanelli M, Claxton K. Wound healing and TIME; new concepts and scientific applications. Wound Repair Regen 2005; 13(4 Suppl): S1-11.
52. Shi L, Ermis R, Kiedaisch B, Carson D. The effect of various wound dressings on the activity of debriding enzymes. Adv Skin Wound Care 2010; 23(10): 456-62.
53. Vanscheidt W. Krill enzymes in the therapy of chronical wounds. Zeitschrift für Vulnerologie 2007; 1: 10-5.